Bio Protocol's token ($BIO) has increased over 200% in the last 14 days due to technical updates, exchange listings, and investments.
125M $BIO Staked After V2 Launchpad and BioXP Rollout
The rally began in late July 2025 when Bio Protocol launched its V2 Launchpad along with BioXP, a system designed to reward staking and community engagement. Following the launch, over 125 million $BIO tokens were staked, marking a 400% increase compared to previous figures. This led to a reduction in circulating supply and increased pressure on prices.
Investments and Coinbase Listing
In July 2025, $BIO was listed on Coinbase, providing access to retail investors. The project also attracted notable backers, with Binance Labs investing in November 2024. Furthermore, it was reported that Arthur Hayes, co-founder of BitMEX, invested $1 million. These events positively impacted market activity.
Impact of Clinical Trial Funding on $BIO Token
Bio Protocol allocated $80,000 to a clinical trial exploring brain health and memory improvement. Holders of $BIO are linked to royalties and intellectual property revenues, enhancing the token's real world value. The announcement of funding resulted in a 25% increase in the $BIO price on the day of the news.
In summary, the success of the $BIO token can be attributed to a combination of upgrades, strategic investments, and a direct connection to biotechnology research, setting it apart in the market.
